Immunogenicity and protective efficacy of an intranasal neuraminidase-based influenza virus vaccine adjuvanted with bacterial cell membrane-derived adjuvants
Kirill Vasilev, Irene Hoxie, Eduard Puente‐Massaguer, Joshua Yueh, Disha Bhavsar, Maya Singh, Corey P. Mallett, Joseph Zimmermann, Florian Krammer
This study evaluates an intranasal influenza vaccine based on neuraminidase (NA) adjuvanted with bacterial membrane-derived components, showing improved immunogenicity and protection against H5N1 challenge.
bioRxiv · Feb 26, 2025 · PreprintMicrobiology